A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Pfizer
Ossium Health, Inc.
St. Jude Children's Research Hospital
City of Hope Medical Center
Seagen Inc.
Mayo Clinic
Compass Therapeutics
GlaxoSmithKline
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
Shattuck Labs, Inc.
Cedars-Sinai Medical Center
Bio-Path Holdings, Inc.
Takeda
Columbia University
Mundipharma Research Limited
Pfizer
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
University of Nebraska
University of Nebraska
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Seagen Inc.
Atara Biotherapeutics
Scripps Health
Columbia University
Roswell Park Cancer Institute
Peter MacCallum Cancer Centre, Australia
Russian Academy of Medical Sciences
Rutgers, The State University of New Jersey
Northwestern University
Northwestern University
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Seagen Inc.
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center